Walleye Trading
XBI icon

Walleye Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Walleye Trading’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.5M Sell
261,900
-320,700
-55% -$40M 0.06% 340
2025
Q4 		$71M Buy
582,600
+322,400
+124% +$37M 0.1% 203
2025
Q3 		$26.1M Sell
260,200
-5,100
-2% -$459K 0.04% 483
2025
Q2 		$22M Sell
265,300
-100,600
-27% -$8.03M 0.04% 490
2025
Q1 		$29.7M Sell
365,900
-399,400
-52% -$35.7M 0.07% 310
2024
Q4 		$68.9M Sell
765,300
-95,500
-11% -$9.25M 0.14% 129
2024
Q3 		$85M Sell
860,800
-252,400
-23% -$24.8M 0.18% 90
2024
Q2 		$103M Buy
1,113,200
+392,900
+55% +$35.2M 0.24% 61
2024
Q1 		$68.3M Buy
720,300
+316,000
+78% +$29.3M 0.15% 109
2023
Q4 		$36.1M Buy
404,300
+10,700
+3% +$795K 0.08% 241
2023
Q3 		$28.7M Buy
393,600
+25,200
+7% +$2.01M 0.08% 251
2023
Q2 		$30.7M Sell
368,400
-481,600
-57% -$40.3M 0.09% 195
2023
Q1 		$64.8M Buy
850,000
+390,500
+85% +$32.4M 0.14% 96
2022
Q4 		$38.1M Buy
459,500
+164,900
+56% +$13.4M 0.11% 186
2022
Q3 		$23.4M Buy
294,600
+102,700
+54% +$8.66M 0.07% 273
2022
Q2 		$14.3M Buy
191,900
+123,700
+181% +$9.29M 0.05% 452
2022
Q1 		$6.13M Buy
68,200
+50,400
+283% +$4.65M 0.02% 883
2021
Q4 		$1.99M Sell
17,800
-165,600
-90% -$20M 0.01% 1647
2021
Q3 		$23.1M Buy
183,400
+164,100
+850% +$21.1M 0.08% 244
2021
Q2 		$2.61M Sell
19,300
-40,700
-68% -$5.35M 0.01% 1276
2021
Q1 		$8.14M Buy
60,000
+51,100
+574% +$7.65M 0.04% 410
2020
Q4 		$1.25M Sell
8,900
-8,800
-50% -$1.13M 0.01% 1782
2020
Q3 		$1.97M Buy
17,700
+3,400
+24% +$381K 0.01% 1131
2020
Q2 		$1.6M Buy
14,300
+3,400
+31% +$335K 0.01% 1277
2020
Q1 		$844K Sell
10,900
-17,500
-62% -$1.55M 0.01% 1430
2019
Q4 		$2.7M Buy
28,400
+11,200
+65% +$969K 0.02% 984
2019
Q3 		$1.31M Buy
17,200
+10,100
+142% +$839K 0.01% 1392
2019
Q2 		$623K Sell
7,100
-35,900
-83% -$3.06M 0.01% 2003
2019
Q1 		$3.89M Sell
43,000
-4,900
-10% -$417K 0.03% 634
2018
Q4 		$3.44M Buy
47,900
+19,500
+69% +$1.57M 0.03% 688
2018
Q3 		$2.72M Sell
28,400
-56,300
-66% -$5.46M 0.01% 1058
2018
Q2 		$8.06M Buy
84,700
+27,300
+48% +$2.51M 0.04% 373
2018
Q1 		$5.04M Buy
57,400
+17,200
+43% +$1.57M 0.03% 531
2017
Q4 		$3.4K Buy
40,200
+12,300
+44% +$1.03M 0.02% 904
2017
Q3 		$2.42K Buy
27,900
+12,300
+79% +$986K 0.01% 1131
2017
Q2 		$1.21K Sell
15,600
-17,500
-53% -$1.24M 0.01% 1598
2017
Q1 		$2.3K Buy
33,100
+14,800
+81% +$994K 0.02% 990
2016
Q4 		$1.08M Buy
18,300
+16,900
+1,207% +$1.04M 0.01% 1449
2016
Q3 		$93K Buy
+1,400
New +$86.6K ﹤0.01% 3352

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Walleye Trading's XBI Position: Q1 2026 in Review

Walleye Trading increased its State Street SPDR S&P Biotech ETF (XBI) stake by 190% in Q1 2026, buying an estimated $23.5M and bringing the position to 287,721 shares worth $36.8M. The position accounts for 0.06% of the portfolio, ranked #311.

Walleye Trading first reported a position in XBI in Q1 2017 and has held it in 23 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Walleye Trading held 287,721 shares of State Street SPDR S&P Biotech ETF worth $36.8M as of Q1 2026.
  • Walleye Trading bought 188,401 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $23.5M.
  • State Street SPDR S&P Biotech ETF made up 0.06% of Walleye Trading's portfolio in Q1 2026, its #311 holding.
  • Walleye Trading first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 23 quarters since.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.